Managing Partner, Qiming Venture Partners
Nisa Leung is a managing partner of Qiming Venture Partners, leading its healthcare investments. Qiming currently manages over USD 4 billion in assets and investment in over 280 companies.
Ms Leung was named Venture Capital Professional of the Year by Asian Venture Capital Journal in 2017. She currently sits on the board of Gan & Lee Pharmaceutical, Zai Lab (NASDAQ: ZLAB), Nurotron, Venus MedTech, Goodwill Information Technology, dMed, LIH Rehabilitation, CanSino Biotechnology, New Horizon Bio and Berry Oncology among others.
Ms Leung earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is currently a visiting lecturer at Harvard Law School and a founding vice chair of PhIRDA Investment Committee.